| Net income (loss) | |
| Depreciation and amortization | 3.42M |
| Deferred tax expense (benefit) | 2.29M |
| Stock-based compensation | 1.69M |
| Unrealized (gain)/loss on foreign currency translation | -1K |
| Accounts receivable | 377K |
| Inventories | -5.66M |
| Other current assets | 197K |
| Accounts payable | -1.82M |
| Accrued liabilities | 475K |
| Deferred revenue and other liabilities | -2.61M |
| Net cash provided by (used in) operating activities | 1.88M |
| Purchase of property and equipment | -2.13M |
| Net cash provided by (used in) investing activities | -1.3M |
| Proceeds from issuance of common stock | 567K |
| Proceeds from (repayments of) line of credit borrowings, net | 1.41M |
| Proceeds from (repayments of) debt, net | -279K |
| Net cash provided by (used in) financing activities | 1.7M |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | 39K |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 2.32M |
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | 6.89M |
| CASH AND CASH EQUIVALENTS, END OF PERIOD | 9.21M |
| Cash paid for interest | |
| Non-cash transfer of inventory to property and equipment | |